The European Patent Office (EPO) has published patent application EP4619454A1, filed by Evonik Operations GmbH, concerning novel polyoxyalkylene-1,2-dimyristoyl-glycerol compounds. The patent specifically details compounds where the polyoxyalkylene component is a poly(ethylene oxide) with C1 to C3-alkyloxymethyl side chains. This publication is a standard part of the EPO's patent bulletin process for pharmaceutical-related inventions.

This is a patent publication, not a regulatory rule or enforcement action. It grants intellectual property protection for the described compounds and does not impose new compliance obligations on regulated entities. Companies operating in the pharmaceutical or chemical manufacturing sectors may wish to review the patent for competitive intelligence or potential licensing opportunities. No immediate compliance actions are required.